Add to ORKGINTRODUCTION: Intensive control of blood glucose in diabetic patients is associated with suboptimal survival.1 In the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, 10 104 patients were randomized to intensive or standard therapy (target glycated haemoglobin levels <6.0% vs 7-7.9%) for a mean treatment …published_or_final_versionThe 17th Medical Research Conference, The University of Hong Kong, Hong Kong, 14 January 2012. In Hong Kong Medical Journal, 2012, v. 18 suppl. 1, p. 29, abstract no. 3
BACKGROUND: In patients with type 2 diabetes, the effects of intensive glucose control on vascular o...
Introduction: Hyperglycemia and insulin resistance are common in critically ill patients, even if th...
In the ACCORD trial, intensive treatment of patients with type 2 diabetes and high cardiovascular (C...
Oral Presentations - Endocrinology and Metabolism: no. C071It has been reported that intensive contr...
Background: Whether intensive control of glucose reduces macrovascular events and all-cause morta...
BACKGROUND—Intensive glucose lowering has previously been shown to increase mortality among persons ...
Introduction: The effect of intensive glycaemic control alone or as part of a multifactorial interv...
Aims/hypothesis: Intensive glucose control reduces the risk of vascular complications while increasi...
Background—Epidemiologic studies have shown a relationship between glycated hemoglobin levels and ca...
OBJECTIVE — To determine if baseline subgroups in the Action to Control Cardiovascular Risk in Diabe...
BACKGROUND: Severe hypoglycemia may increase the risk of a poor outcome in patients with type 2 diab...
OBJECTIVE — Randomized treatment comparing an intensive glycemic treatment strategy with a standard ...
Objective To determine whether there is a link between hypoglycaemia and mortality among participant...
In the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, ∼4 years of intensive versu...
Context: Glycemic targets and the benefit of intensive glucose control are currently under debate be...
BACKGROUND: In patients with type 2 diabetes, the effects of intensive glucose control on vascular o...
Introduction: Hyperglycemia and insulin resistance are common in critically ill patients, even if th...
In the ACCORD trial, intensive treatment of patients with type 2 diabetes and high cardiovascular (C...
Oral Presentations - Endocrinology and Metabolism: no. C071It has been reported that intensive contr...
Background: Whether intensive control of glucose reduces macrovascular events and all-cause morta...
BACKGROUND—Intensive glucose lowering has previously been shown to increase mortality among persons ...
Introduction: The effect of intensive glycaemic control alone or as part of a multifactorial interv...
Aims/hypothesis: Intensive glucose control reduces the risk of vascular complications while increasi...
Background—Epidemiologic studies have shown a relationship between glycated hemoglobin levels and ca...
OBJECTIVE — To determine if baseline subgroups in the Action to Control Cardiovascular Risk in Diabe...
BACKGROUND: Severe hypoglycemia may increase the risk of a poor outcome in patients with type 2 diab...
OBJECTIVE — Randomized treatment comparing an intensive glycemic treatment strategy with a standard ...
Objective To determine whether there is a link between hypoglycaemia and mortality among participant...
In the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, ∼4 years of intensive versu...
Context: Glycemic targets and the benefit of intensive glucose control are currently under debate be...
BACKGROUND: In patients with type 2 diabetes, the effects of intensive glucose control on vascular o...
Introduction: Hyperglycemia and insulin resistance are common in critically ill patients, even if th...
In the ACCORD trial, intensive treatment of patients with type 2 diabetes and high cardiovascular (C...